Pfizer

Pfizer To Sell €2.96bn Stake In Sensodyne Maker Haleon

Pfizer will sell shares worth £2.50 billion ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% fr...

Haleon To Sell Nicotine Replacement Therapy Business Outside US

Haleon will sell its nicotine replacement therapy business outside the US to a unit of India's Dr. Reddy's for £500 million (€592.23 million), t...

GSK Raises £1.25bn From Offloading Haleon Stake At A Discount

GSK has raised £1.25 billion (€1.46 billion). from selling its entire remaining stake in consumer healthcare firm Haleon, the British drugmaker...

Haleon Posts Tepid Q1 Sales As Demand For Some Products Cool Off

Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates as volumes declined.

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon To 24%

Consumer healthcare firm Haleon has said that U.S. drugmaker Pfizer, its top shareholder, will sell down its stake in the company to about 24%.

GSK Cuts Stake In Haleon To 7.4%, Raises £885.6m

British drugmaker GSK said it raised £885.6 million (€1 billion) from a discounted stake sale in Haleon, cutting its shareholding to 7.4%.

Sensodyne Toothpaste-Maker Haleon Planning Job Cuts - The Guardian

Haleon, the world's biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and potentially thousands worldwide, the Gu...

GSK Sells $1bn Discounted Stake In Spin-Off Haleon

British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about £804 million...